Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Assisted Reproduction and Genetics"
DOI: 10.1007/s10815-017-1041-0
Abstract: PurposeThe aim of this study was to confirm the associated M2/ANXA5 carrier risk in women with placenta-mediated pregnancy complications (PMPC) and to test their male partners for such association. Further analysis evaluated the influence of… read more here.
Keywords: mediated pregnancy; pregnancy; pregnancy complications; haplotype ... See more keywords
Assessment-based management of placenta-mediated pregnancy complications: Pragmatism until a precision medicine approach evolves.
Sign Up to like & getrecommendations! Published in 2023 at "British journal of haematology"
DOI: 10.1111/bjh.18856
Abstract: The management of pregnant women with thrombophilia and a history of gestational vascular complications remains debatable. Treatment of the latter is often based on clinical outcome rather than disease mechanism. While the use of venous… read more here.
Keywords: precision medicine; pregnancy complications; management; placenta mediated ... See more keywords
Effects of Salvia miltiorrhiza active compounds on placenta-mediated pregnancy complications
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2023.1034455
Abstract: Placenta-mediated pregnancy complications (PMPCs), including preeclampsia (PE), fetal growth restriction (FGR), and recurrent spontaneous abortion (RSA), occur in approximately 5% of pregnancies and are caused by abnormal placenta development. The development of effective therapies for… read more here.
Keywords: miltiorrhiza active; salvia miltiorrhiza; active compounds; pregnancy complications ... See more keywords